You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

NICE recommends Janssen’s treatment for active psoriatic arthritis

Tremfya – also known as guselkumab – has been recommended by the National Institute for Health and Care Excellence (NICE) for people with active psoriatic arthritis whose disease does not respond to conventional disease-modifying anti-rheumatic drugs (DMARDs).